Related Experiment Video
Updated: Nov 16, 2025

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
Drivers of Gene Expression Dysregulation in Pancreatic Cancer
Swati Venkat1, Abdulrahman A Alahmari2, Michael E Feigin1
1Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Abstract:
Pancreatic ductal adenocarcinoma (PDAC) remains a devastating disease with a poor prognosis. The functional consequences of common genetic aberrations and their roles in treatment strategies have been extensively reviewed. In addition to these genomic aberrations, consideration of non-genetic drivers of altered oncogene expression is essential to account for the diversity in PDAC phenotypes. In this review we seek to assess our current understanding of mechanisms of gene expression dysregulation. We focus on four drivers of gene expression dysregulation, including mutations, transcription factors, epigenetic regulators, and RNA stability/isoform regulation, in the context of PDAC pathogenesis. Recent studies provide much-needed insight into the role of gene expression dysregulation in dissecting tumor heterogeneity and stratifying patients for the development of personalized treatment strategies.
Insights
Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer. Understanding gene expression changes beyond genetics, like epigenetic factors, is key to developing new treatments and personalizing patient care.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Pancreatic ductal adenocarcinoma (PDAC) presents a significant clinical challenge due to its poor prognosis.
- While genetic mutations are well-studied, non-genetic factors also drive PDAC progression and treatment resistance.
- Tumor heterogeneity in PDAC necessitates a deeper understanding of gene expression regulation.
Purpose of the Study:
- To review current knowledge on mechanisms of gene expression dysregulation in PDAC.
- To highlight the role of non-genetic drivers in PDAC pathogenesis.
- To explore how understanding gene expression can aid in personalized medicine for PDAC.
Main Methods:
- Literature review focusing on PDAC.
- Analysis of gene expression regulatory mechanisms.
- Synthesis of findings related to mutations, transcription factors, epigenetic regulators, and RNA regulation.
Main Results:
- Gene expression is altered by mutations, transcription factors, epigenetic modifications, and RNA stability/isoform regulation in PDAC.
- These non-genetic factors contribute significantly to PDAC phenotypes and heterogeneity.
- Insights into these mechanisms are emerging from recent studies.
Conclusions:
- Gene expression dysregulation is a critical aspect of PDAC pathogenesis.
- Targeting non-genetic drivers offers potential for novel therapeutic strategies.
- Understanding these mechanisms is vital for patient stratification and personalized PDAC treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cell Specific Gene Expression
Epigenetic Regulation
X-chromosome...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Canonical Wnt Signaling Pathway

